Psychiatry drugs finally have pharma's attention. Can they keep it?
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Acadia Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Culper Research has taken a short position on Acadia Pharmaceuticals' stock, it said on Thursday, sending the drugmaker's shares down as much as 8%. Acadia's drug, trofinetide, to treat...
(Reuters) -Culper Research has taken a short position on Acadia Pharmaceuticals' stock, it said on Thursday, sending the drugmaker's shares down as much as ...
An analyst upgrade is sparking a rally in the drugmaker's shares today.
Anavex has two big catalysts coming up, both in Alzheimer’s disease and Parkinson’s Disease Dementia.